Without a doubt, the launch environment is more hostile for new product launches and has been moving in that direction long before March of 2020. It is simply getting more difficult and expensive to reach patients and prescribers.
In this issue, we rigorously investigate the past and present in an effort to understand the future. We're challenging ourselves to answer key questions: